JW Therapeutics competitorsClear all
Neovii's top competitors include Foghorn Therapeutics.
 Neovii Neovii is a company specializing in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology and oncology.
|  Foghorn Therapeutics Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors. | |
Founding Date | Founding Date 2003 | Founding Date 2016 |
Type | Type Private | Type Public |
Tags | ||
Locations | Locations Rapperswil-Jona, CH HQ Gräfelfing, DE Lexington, US | Locations Cambridge, US HQ Cambridge, US |
Employees | Employees 89 | Employees 85 |
For sources of this data, please see the company profile
View company profiles
Foghorn Therapeutics
HQ
Cambridge, US
Employees
85
Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.
View company